Cardenas, Ryan, Prinsley, Peter, Philpott, Carl ORCID: https://orcid.org/0000-0002-1125-3236, Bhutta, Mahmood F., Wilson, Emma, Brewer, Daniel S. ORCID: https://orcid.org/0000-0003-4753-9794 and Jennings, Barbara A. ORCID: https://orcid.org/0000-0003-3792-9182 (2023) Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma. PLoS One, 18 (3). ISSN 1932-6203
Wardale, Lewis, Cardenas, Ryan, Gnanapragasam, Vincent J., Cooper, Colin S. ORCID: https://orcid.org/0000-0003-2013-8042, Clark, Jeremy and Brewer, Daniel S. ORCID: https://orcid.org/0000-0003-4753-9794 (2023) Combining molecular subtypes with multivariable clinical models has the potential to improve prediction of treatment outcomes in prostate cancer at diagnosis. Current Oncology, 30 (1). pp. 157-170. ISSN 1198-0052
Cardenas, Ryan, Prinsley, Peter, Philpott, Carl ORCID: https://orcid.org/0000-0002-1125-3236, Bhutta, Mahmood F, Wilson, Emma, Brewer, Daniel S. ORCID: https://orcid.org/0000-0003-4753-9794 and Jennings, Barbara A. ORCID: https://orcid.org/0000-0003-3792-9182 (2022) Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma.
Ball, Richard, Cardenas, Ryan, Winterbone, Mark, Yazbek Hanna, Marcelino, Parker, Christopher C., Hurst, Rachel, Brewer, Daniel ORCID: https://orcid.org/0000-0003-4753-9794, D'Sa, Lauren, Mills, Robert, Cooper, Colin ORCID: https://orcid.org/0000-0003-2013-8042 and Clark, Jeremy (2021) The urine biomarker PUR-4 is positively associated with the amount of Gleason 4 in human prostate cancers. Life, 11 (11). ISSN 2075-1729